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Biologically targeted probes for Zn2+: a diversity
oriented modular “click-SNAr-click” approach†
J. Pancholi,a D. J. Hodson,b K. Jobe,a G. A. Rutter,*b S. M. Goldup*a
and M. Watkinson*a
We describe a one-pot strategy for the high yielding, operationally simple synthesis of fluorescent probes
for Zn2+ that bear biological targeting groups and exemplify the utility of our method through the
preparation of a small library of sensors. Investigation of the fluorescence behaviour of our library
revealed that although all behaved as expected in MeCN, under biologically relevant conditions in HEPES
buffer, a plasma membrane targeting sensor displayed a dramatic switch on response to excess Zn2+ as
a result of aggregation phenomena. Excitingly, in cellulo studies in mouse pancreatic islets demonstrated
that this readily available sensor was indeed localised to the exterior of the plasma membrane and clearly
responded to the Zn2+ co-released when the pancreatic beta cells were stimulated to release insulin.
Conversely, sensors that target intracellular compartments were unaffected. These results demonstrate
that this sensor has the potential to allow the real time study of insulin release from living cells and
exemplifies the utility of our simple synthetic approach.
Introduction
Zinc is now rmly established as an essential trace element,
widely found in proteins where it undertakes both structural
and catalytic roles.1 In addition to these xed forms of biolog-
ical zinc, it is known that pools of loosely bound zinc, oen
referred to as “free” or “mobile”,2 are found in the pancreas,3
central nervous system,4 prostate,5 intestine6 and retina.7 The
biological trafficking of zinc has been linked to many disease
states in these vital organs, including Alzheimer's disease,8
epilepsy,9 ischemic stroke,10 infantile diarrhoea,6 age related
macular degeneration,7 prostate cancer11 and type 2 diabetes.3
For example, polymorphisms in the SLC30A8 gene, encoding
the secretory granule zinc transporter ZnT8 in pancreatic islet b-
cells, are directly associated with type 2 diabetes.3
However, although the importance of mobile zinc in human
health is now well known,12 its role in the physiological changes
leading to the onset and progress of these disease states is not
yet fully understood, to a large extent due to our current
inability to monitor changes inmobile zinc at high resolution in
specic biological space.13 There is therefore a major drive to
develop molecular probes which are able to map Zn2+ levels in
cells and organs via the chelatable mobile pools of zinc present.
Small molecule uorescent probes for Zn2+ consisting of a
chelating unit, attached (directly or indirectly) to a uorescent
moiety can deliver a rapid, strong output signal in response to
binding of Zn2+ at the chelation site, even at very low concen-
trations of the metal ion.14 A wide range of these probes have
now been reported that display an array of metal-binding and
uorescent properties and which, in principle, can be further
tuned through rational synthetic modication.15 We previously
reported probe 1, consisting of a metal chelating tetra-azama-
crocycle, linked to a uorophore by a triazole moiety (Fig. 1a),16
which shows a high selectivity for Zn2+ over other biologically
relevant metals in a suitable pH range. We demonstrated the
utility of probe 1 in vivo in zebrash (Fig. 1b).17 However,
although 1 and other notable rst generation small molecule
Zn2+ probes display high selectivity for zinc,15 they are limited
when judged against the requirements of biological imaging, in
particular the need to target specic cellular and sub-cellular
domains for optimal in vivo imaging, as well as the need to tailor
Fig. 1 (a) Our previously reported first generation Zn2+ sensor 1; (b)
fluorescence microscopy images of Danio rerio (zebrafish) embryo
incubated with sensor 1.
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the metal binding unit in order to detect mobile zinc at a wide
range of biologically relevant concentrations.14d
To overcome this, a limited number of biologically targeted
small molecule uorescent probes for Zn2+ have been devel-
oped.18,19 However, these probes are typically time-consuming
and challenging to prepare (Fig. 2), and this, combined with the
unpredictable nature of biological systems that necessitates a
heuristic approach to probe optimisation, presents a signicant
barrier to their application. Alternatively, targeted recombinant
probes have been shown to permit measurement of Zn2+ at the
subcellular level.20 However, the deployment of these probes in
living cells is oen limited by the need for virus-mediated or
transgenic approaches to allow gene delivery.19c
To facilitate the rapid development of targeted small mole-
cule probes for Zn2+ they should ideally be accessible in a
synthetically exible and succinct manner such that their
properties can be optimised quickly and easily. Herein we
describe such an approach; a diversity-oriented modular, one-
pot synthetic method for the realisation of biologically targeted
Zn2+ sensors and demonstrate its utility through the synthesis
of a small library of sensors with a selection of metal binding
and biological targeting units. The selectivity and sensitivity of
the sensors were studied to conrm that the addition of the
targeting moiety did not signicantly alter zinc binding and
uorescent behaviour. We showcase the potential of our
approach for the development of new sensors for biological
applications through cell-resolution Zn2+ imaging studies in
living pancreatic islets.
Results and discussion
To develop an expedient, modular approach to targeted sensors
we decided to build on the success of sensor 1, the synthesis of
which employed a high yielding Cu-mediated alkyne–azide
cycloaddition (CuAAC) reaction, oen simply called the “click”
reaction.21,22 The generality of this reaction, its operational
simplicity and the availability of suitable alkyne and azide
starting materials has rapidly elevated it to a method of choice
for the synthesis of complex non-natural molecular targets23
since it was rst disclosed independently by Sharpless and
Fokin, and Meldal in 2002. With a view to increasing the
operational simplicity still further, we decided to develop a one-
pot iterative methodology in which the targeting unit and the
metal binding moiety are combined sequentially with a readily
available uorophore core.
Development of a click-SNAr-click approach for the synthesis
of targeted probes for Zn2+
One-pot iterative click approaches have previously been devel-
oped that exploit the differential reactivity of dissimilar azide or
alkyne functionality,24 or in which the second alkyne or azide
component is formed in situ.25 The latter typically rely on the use
of masked alkyne units such as silyl-protected acetylenes,26 or
masked azides in the form of leaving groups at sp3 centres.27,28
Instead we decided to focus on a novel SNAr approach that
makes use of the unusual reactivity of the electron-decient
naphthalimide core of 1.29
Building block 2 was synthesised in high yield (96%) in one
step from commercially available 4-bromo-1,8-naphthalic
anhydride. We optimised our iterative approach using benzyl
azide and phenyl acetylene as model substrates. Acetylene 2
readily participated in the click reaction with benzyl azide in
NMP in the presence of CuI. Subsequent addition of NaN3 to the
reaction mixture led to the SNAr displacement of the bromide
leaving group to give the required azide functionality for the
second click reaction. The second coupling step proved more
problematic. Firstly, the NaBr by-product of the SNAr reaction
was revealed to inhibit the click reaction in NMP, leading to
slower reactions and signicant levels of decomposition
compared with the stepwise process. Rather than using silver
salts to scavenge the bromide ions, this problem was overcome
though the addition of EtOH as a co-solvent during the second
click reaction, which presumably solvates the bromide anion.
Secondly, even with this modication the nal click reaction
proved sluggish at room temperature. This was overcome by the
addition of NaOAc as a base to accelerate the reaction.30
Combining these results led to conditions under which the
click-SNAr-click sequence could be performed in one-pot over a
40 h period at room temperature through simple sequential
addition of reagents with purication only performed aer the
nal step (Fig. 3). Gratifyingly, in addition to being operation-
ally trivial, and time and reagent efficient, the isolated yield of
the one pot procedure signicantly exceeded that of the step-
wise process with model compound 4 produced in 85% yield
compared with 41% with isolation and purication aer each
step.
With an effective iterative procedure in hand we investigated
its utility through the synthesis of targeted sensors for Zn2+
based on metal binding units previously reported to confer a
selective response to zinc15,16 and a selection of readily available
biological targeting units. Accordingly, starting from 2 we syn-
thesised sensors 6–8 that are designed to interdigitate in the cell
membrane through the lipophilic di-dodecylamide motif,13 but
Fig. 2 Representative examples of previously reported sensors for
Zn2+ incorporating biological targeting units.19
This journal is © The Royal Society of Chemistry 2014 Chem. Sci., 2014, 5, 3528–3535 | 3529
Edge Article Chemical Science
in which the metal binding unit is varied between dipicolyl-
amine (6), aminodiacetate (7) and cyclam (8). Having demon-
strated the exibility of our approach with respect to the metal
binding unit we investigated simple variations in the targeting
unit through the synthesis of sensors bearing a phosphonium
salt previously demonstrated to target the mitochondria (9)19d
and a simple bis-amide, which has been shown to accumulate
in the lysosomal space (10).19e
Finally, given that a wide range of propargylated biological
motifs are available, in particular propargyl glycosides,31 we
extended our iterative approach to azide functionalised
building block 3 which is readily synthesised from 4-bromo-
napthalic anhydride (2 steps, 79% overall yield) and evaluated
its behaviour under our optimised to conditions. Pleasingly, 3
was converted to model compound 5 by iterative one-pot reac-
tion with two portions of phenyl acetylene in excellent yield.
Using these conditions, sensor 11, which bears a representative
protected glycoside, was produced in excellent yield, further
extending the utility of our iterative click approach.
All sensors were isolated in good to excellent yield over 3
steps; 61–82% overall, which corresponds to an average of 85–
92% for each chemical step. These results clearly show that our
iterative method can be used to prepare sensors efficiently and
rapidly by combining biological targeting groups bearing either
an alkyne or an azide with uorescent cores 2 or 3 respectively,
and metal binding domains functionalised with an acetylene
handle.
Fluorescent properties of our targeted Zn sensors
The combinations of metal binding unit and uorophore in
sensors 6–11 are based on previously reported selective sensors
for Zn2+ with an expected 1 : 1 binding stoichiometry. In order
to conrm that our novel sensor constructs maintain these
selective properties with the inclusion of a targeting unit we
investigated their response to Zn2+ in both MeCN and HEPES
buffer (Fig. 4). Where necessary, the metal binding domains
and biological targeting units were deprotected using standard
procedures prior to testing (see ESI† for full details).
In all cases, the sensors responded to 1 equivalent of Zn2+ in
MeCN as expected with switch-on uorescent enhancements of
between 2- and 4.5-fold observed, and little or no further
enhancement with the addition of further equivalents of Zn2+
(Fig. 4a).13–15 Similarly, with the exception of sensors 6 (vide
infra) and 7, which precipitated on addition of Zn2+, the probes
responded as expected in HEPES buffer, producing similar or
enhanced on/off ratios to those observed in MeCN (Fig. 4b).
Dissociation constants (Kd) were determined by non-linear
regression analysis of titrated samples of sensors 8–11, in
HEPES assuming a 1 : 1 binding stoichiometry. Although
reasonable values of Kd were obtained when compared to those
reported for structurally similar ligands,15r,16a,32 the goodness of
t to a 1 : 1 binding model varied considerably (see ESI† for full
details). Similar issues have recently been identied by Ceroni,
Doddi and co-workers in their investigations of dendrimeric
cyclam sensors for Zn2+,33 and work is currently underway to
determine the origin of these effects in our systems. In
summary, these in vitro results clearly demonstrate that the
selective switch on response of probes 6–11 to zinc is not
affected by the inclusion of a biological targeting group.
Investigation of the anomalous behaviour of sensor 6
The behaviour of sensor 6 in HEPES buffer proved more
complicated than that of the other sensors investigated;
Fig. 3 Our one-pot iterative click approach to targeted sensors for
Zn2+. aisolated yield from one-pot synthesis. bFor deprotection
conditions and yields see ESI.†
Fig. 4 Fluorescence switch-on response to Zn2+ of sensors 6–11 in (a)
MeCN and (b) HEPES buffer. Emission intensity (F) in the presence of 1
(red) or 5 (blue) eq. Zn2+ relative to the emission intensity of the sensor
alone (F0, black, normalised to 1).
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addition of further equivalents of Zn2+ led to further signicant
increases in uorescence up to a maximum value of 15-fold
uorescence enhancement with 15 equiv. Zn2+ (c.f. 5.1 for 1
equiv. of Zn2+) at our standard sensor concentration of 50 mM.
Along with the enhanced uorescence response, a red shi in
the emission maximum was observed (23 nm and 31 nm at 1
and 15 eq. Zn2+ respectively). Having observed that solutions of
6 in HEPES were slightly turbid and that their visual appearance
changed on addition of Zn2+ (Fig. 5a) we hypothesised that this
unusual behaviour might be due to aggregation phenomena,
driven by the surfactant-like nature (polar dipicolylamine head
group, lipophilic aliphatic tail) of the sensor construct, which
the addition of Zn2+ could serve to modulate.34 In keeping with
this hypothesis, increasing the probe concentration to 100 mM
led to an even more dramatic 35-fold increase in uorescence
intensity in the presence of 15 eq. of Zn2+, while at a sensor
concentration of 10 mM the response to excess Zn2+ was
reduced. Dynamic light scattering (DLS) experiments conrmed
the presence of aggregates and, importantly, that the average
size and polydispersity of the aggregates decreases signicantly
on addition of Zn2+ and that these aggregates remained even
when probe concentration was signicantly reduced to 10 mM.
No such aggregation was observed in MeCN.
To examine this further, we investigated the effect of solvent
composition on the uorescence of sensor 6, in mixtures of
HEPES and MeCN.34b In the absence of Zn2+, the uorescence
output and emission wavelength of 6 remained largely
unchanged as the v/v% of HEPES in MeCN was varied.
Conversely, in the presence of Zn2+ a steady increase in uo-
rescence output was observed up to 60% v/v HEPES, above
which a signicant drop in the uorescence output was
observed, which coincides with the red shi observed in the
uorescence emission (Fig. 5b).
Thus, it appears that two factors play a role in the dramatic
sensitivity of sensor 6: (i) as in all the other sensors synthesised,
binding of Zn2+ to the ligand unit deactivates the PET quench-
ing process leading to a “switch on”; (ii) the aggregation of the
unbound sensor initially serves to quench the emission but
binding of Zn2+ changes the aggregation such that uorescence
is recovered. Importantly, when sensor 8b was examined by
DLS, aggregation was not observed, highlighting the subtle role
that small structural changes can have on sensor performance.
Finally, given the important role that aggregation plays in the
performance of sensor 6 in vitro, and that the binding of other
metal ions could possibly inuence aggregation signicantly
leading to a loss of selective Zn2+ sensing behaviour, we vali-
dated the selectivity of 6 for zinc ions. Pleasingly, only Cd2+ and
Hg2+ produced a uorescent response with sensor 6, which is to
be expected based on previous studies and is not biologically
relevant.15b All other metal ions tested led either to no change in
uorescent output or quenching of the background uores-
cence. Importantly, probe 6 retains its switch on response for
Zn2+ in physiological buffer and over a physiological relevant
range of pH.
In vitro application of sensor 6 to monitor exocytosis via the
release of Zn2+ in pancreatic islet cells
The release of insulin from pancreatic b-cells is associated with
the concomitant release of Zn2+-containing granules, which
allows the changes in the concentration of Zn2+ on the exterior of
the plasma membrane to be used as a proxy for the release of
insulin. This approach has been rened in recent work by Li and
co-workers through the development of ZIMIR, a selective sensor
for Zn2+ that anchors on the extracellular face of the plasma
membrane and can be used to monitor the response of the
pancreatic cells to various stimuli with high spatial resolution.18
The structure and in vitro behavior of sensor 6 bear
remarkable similarities to ZIMIR in that both: (i) possess a
surfactant-like structure which in the case of ZIMIR has been
shown to localize the sensor to the extracellular face of the
plasma membrane; (ii) display a large increase in uorescence
output in the presence of excess Zn2+ (70-fold in the case of
ZIMIR, 35 fold in the case of sensor 6); (iii) demonstrate selec-
tivity for Zn2+ over other biologically available divalent metal
ions. Given the utility of ZIMIR in monitoring the stimulated
efflux of zinc, we decided to evaluate probe 6 in cellulo to see if it
displayed similar membrane targeting behaviour.
Sensor 6 (30 mM) was incubated with pancreatic islet cells for 1
h, which were then washed under a steady ow of biological buffer
for the remainder of the experiment to remove unbound sensor. In
order to overcome the less favourable absorption/emission prole
of sensor 6 compared with ZIMIR (lex ¼ 493 nm, lem ¼ 518 nm vs
lex ¼ 347 nm, lem ¼ 443 nm), the cells were imaged using 2-
photon excitation (lex ¼ 850 nm), which is fast-becoming the
Fig. 5 (a) Visualisation of aggregating sensor 6 at 100 mM in HEPES
buffer indicating decreasing visual turbidity upon addition of excess
Zn2+ (from L–R: 0, 1, 5, 15 eq. Zn2+); (b) visualisation of aggregating
sensor 6 at 100 mM in HEPES buffer under UV lamp (lex ¼ 365 nm)
(from L–R: 0, 1, 5, 15 eq. Zn2+); (c) HEPES/MeCN titration of aggre-
gating sensor 6 demonstrating both the change in fluorescence
emission and red the shift of the emission wavelength upon increasing
the percentage of HEPES in MeCN.
This journal is © The Royal Society of Chemistry 2014 Chem. Sci., 2014, 5, 3528–3535 | 3531
Edge Article Chemical Science
imaging modality of choice, to visualise the distribution of the 6
within the rst few islet layers. Aer incubation and irrigation with
buffer, sensor 6 remained clearly localised on the cell surface,
appearing to stain the plasma membrane in a manner similar to
ZIMIR with little or no internalisation of the probe over the time
scale of the experiment.
Having demonstrated that sensor 6 displays the expected
cell-membrane targeting behaviour, we used epiuorescence
microscopy to investigate the probe's response to changes in the
extracellular concentration of Zn2+. Trivially, addition of extra-
cellular Zn2+ led to an increase in uorescence, conrming that
6 is indeed anchored on the extracellular face of the plasma
membrane (Fig. 6b). More interestingly, when KCl was admin-
istered, to cause membrane depolarisation and release of
insulin and Zn2+ into the extracellular space,35 sensor 6
exhibited a strong uorescence response (Fig. 6c) in a manner
similar to that previously observed with ZIMIR. These results
suggest that readily available sensor 6 could also be used tomap
the release of insulin at the cellular level but has the advantage
of being signicantly less challenging to prepare than ZIMIR.
Intriguingly, when the same experiment was attempted with
sensor 8b, despite the structurally similarity to sensor 6 (polar
metal binding unit, lipophilic tail), no increased uorescence
response in the cell membrane was observed (see ESI†). This
result, combined with the unexpected insolubility of the zinc
complex of sensor 7, which could also be expected to act as a
membrane targeting probe, demonstrates the “trial and error”
nature of sensor design for biological applications which our
diversity oriented approach can facilitate.
In order to further demonstrate that the behaviour of the
membrane targeting probe 6 relies on it being localised on the
extracellular face of the plasmamembrane, and also that probes
based on our new general sensor scaffold are capable of tar-
geting intracellular organelles, we also examined probes 9b and
10b which were designed to target specic organelles in cellulo.
Aer incubation, the cellular distributions of 9b and 10b were
different to that of 6, and from one another (Fig. 6a and b): both
probes displayed an extranuclear localisation with a punctate
appearance consistent with their presence in or on intracellular
organelles. However, the appearance of islets incubated with
sensor 10b, which is designed to target the lysosome, is quali-
tatively different to those incubated with mitochondria targeted
probe 9b, with 10b localised in larger bodies. The selective and
differential localisation of 9b and 10b was conrmed by co-
localisation with Mitotracker and Lysotracker respectively
(Fig. 7c).36 In keeping with the complete internalisation of
probes 9b and 10b, addition of extracellular Zn2+ was shown to
result in essentially no change in their uorescence response
(Fig. 7d). Conversely, when pyrithione, which permits transport
of Zn2+ across the plasma membrane, and Zn2+ were co-
administered, both 9b and 10b showed a signicant increase in
uorescence (Fig. 7e). Finally, we were also able to show that
none of the probes were cytotoxic as incubation of mouse islets
with probes 6, 9b and 10b does not signicantly induce cell
death (necrosis) compared to DMSO-alone (see ESI†).
Fig. 6 Fluorescence study of primary mouse islets of Langerhans
incubated for 1 h with 6 (30 mM). (a) Two photon image (lex ¼ 850 nm,
lem ¼ 400–550 nm, max z-projection 80–100 mm); Response of
sensor 6 over time to exogenous (b) 10 mM ZnCl2 and (c) 20 mM KCl
measured by epifluorescence microscopy. (d) Epifluorescence images
demonstrating the response to Zn2+ co-released with insulin from
dense core secretory granules after stimulation with KCl (20 mM).
Fig. 7 Epifluorescence study of sensors 9b and 10b (300 mM). Two
photon image of sensor 9b (lex¼ 850 nm, lem¼ 400–550 nm, max z-
projection 80–100 mm); (b) as for (a) but sensor 10b. (c) comparison of
co-localisation coefficients for sensors 9b and 10b with (i) Mitotracker
and (ii) Lysotracker; (d) response over time of sensor 9b to exogenous
(d) ZnCl2 and (e) 100 mM ZnCl2 co-administered with 5 mM pyrithione.
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Conclusions
We describe here the development of a new range of targeted
Zn2+ sensors that can be efficiently synthesised in high yield in
an operationally simple manner. We anticipate that this
approach will signicantly accelerate the development of
probes for application in biological systems. The importance of
ease of synthesis in order to overcome the difficulties associated
with their trial and error optimisation in cellulo was inadver-
tently exemplied through the disparate behaviour of sensors
6–8, all of which were originally anticipated to be suitable for
staining the plasmamembrane in biological systems. Testing of
sensors bearing representative targeting units in pancreatic
islet cells demonstrated not only their differential localisation
but also their divergent responses to extracellular stimuli,
suggestive of applications in the study of Zn2+ trafficking in the
subcellular space. In particular, sensor 6 allowed us to monitor
insulin release in vitro in living pancreatic islet cells, using Zn2+
as a proxy, in a manner analogous to ZIMIR. This is suggestive
of great potential in the high-resolution imaging of insulin
secretion, an important goal in the study of diabetes. Thus our
modular synthetic approach will facilitate the optimisation and
application of targeted Zn2+ sensors for biology, allowing the
manufacture of tailor-made probes, such 6, with applicability
for the study of Zn2+-signalling and insulin exocytosis.
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